Ad is loading...
ESMC
Price
$0.16
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
One day until earnings call
MDRSF
Price
$66.68
Change
-$0.00 (-0.00%)
Updated
Oct 21 closing price
Ad is loading...

ESMC vs MDRSF

Header iconESMC vs MDRSF Comparison
Open Charts ESMC vs MDRSFBanner chart's image
Escalon Medical
Price$0.16
Change-$0.00 (-0.00%)
Volume$6.91K
CapitalizationN/A
MEDARTIS HOLDING AG
Price$66.68
Change-$0.00 (-0.00%)
Volume$500
CapitalizationN/A
ESMC vs MDRSF Comparison Chart
Loading...
View a ticker or compare two or three
VS
ESMC vs. MDRSF commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESMC is a Hold and MDRSF is a Hold.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ESMC: $0.16 vs. MDRSF: $66.68)
Brand notoriety: ESMC and MDRSF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ESMC: 110% vs. MDRSF: 188%
Market capitalization -- ESMC: $2.08M vs. MDRSF: $1.15B
ESMC [@Medical Specialties] is valued at $2.08M. MDRSF’s [@Medical Specialties] market capitalization is $1.15B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESMC’s FA Score shows that 0 FA rating(s) are green whileMDRSF’s FA Score has 1 green FA rating(s).

  • ESMC’s FA Score: 0 green, 5 red.
  • MDRSF’s FA Score: 1 green, 4 red.
According to our system of comparison, MDRSF is a better buy in the long-term than ESMC.

Price Growth

ESMC (@Medical Specialties) experienced а +6.67% price change this week, while MDRSF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

ESMC is expected to report earnings on Nov 18, 2024.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
MDRSF($1.15B) has a higher market cap than ESMC($2.08M). MDRSF YTD gains are higher at: -14.469 vs. ESMC (-38.709). MDRSF has higher annual earnings (EBITDA): 11.7M vs. ESMC (375K). MDRSF has more cash in the bank: 20.6M vs. ESMC (544K). ESMC has less debt than MDRSF: ESMC (973K) vs MDRSF (27.5M). MDRSF has higher revenues than ESMC: MDRSF (183M) vs ESMC (12M).
ESMCMDRSFESMC / MDRSF
Capitalization2.08M1.15B0%
EBITDA375K11.7M3%
Gain YTD-38.709-14.469268%
P/E Ratio9.85N/A-
Revenue12M183M7%
Total Cash544K20.6M3%
Total Debt973K27.5M4%
FUNDAMENTALS RATINGS
ESMC: Fundamental Ratings
ESMC
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
82
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IFTSX10.150.04
+0.40%
Voya International High Div Low Vol S
MSGTX13.08N/A
N/A
Morgan Stanley Inst Glbl Infras C
IRLCX41.29-0.62
-1.48%
Voya Russell Large Cap Index Port S
USAAX41.23-0.86
-2.04%
Victory Growth
JGRJX38.40-0.85
-2.17%
JPMorgan Growth Advantage R2

ESMC and

Correlation & Price change

A.I.dvisor tells us that ESMC and MDRSF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESMC and MDRSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESMC
1D Price
Change %
ESMC100%
N/A
MDRSF - ESMC
21%
Poorly correlated
N/A
MASI - ESMC
9%
Poorly correlated
+0.57%
FONR - ESMC
8%
Poorly correlated
-2.97%
MDT - ESMC
8%
Poorly correlated
+1.78%
HBIO - ESMC
-1%
Poorly correlated
-6.55%
More

MDRSF and

Correlation & Price change

A.I.dvisor tells us that MDRSF and NHNKF have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MDRSF and NHNKF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDRSF
1D Price
Change %
MDRSF100%
N/A
NHNKF - MDRSF
28%
Poorly correlated
N/A
FNA - MDRSF
24%
Poorly correlated
+3.20%
OSUR - MDRSF
24%
Poorly correlated
-3.51%
MHUA - MDRSF
21%
Poorly correlated
-5.39%
ESMC - MDRSF
21%
Poorly correlated
N/A
More